Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease
Keywords: NAFLD: Non-alcoholic fatty liver disease; Purified long chain omega-3 fatty acids; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid; MRS: magnetic resonance spectroscopy;